Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin

Publisher： Karger

E-ISSN： 1662-0631|4|3|404-409

ISSN： 1662-0631

Source： Case Reports in Gastroenterology, Vol.4, Iss.3, 2010-09, pp. : 404-409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fucidic Acid Use in Metronidazole Nonresponders with Clostridium difficile Infection

By  

Digestion, Vol. 75, Iss. 4, 2007-08 ,pp. : 177-178

Karger

Access to resources Recommend Favorite

Clostridium Difficile Infection Following Chemotherapy

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes

By Moura Ines   Spigaglia Patrizia   Barbanti Fabrizio   Mastrantonio Paola  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 362-365

Oxford University Press

Access to resources Recommend Favorite

Review of medical and surgical management of Clostridium difficile infection

By Faris B.  

Techniques in Coloproctology, Vol. 14, Iss. 2, 2010-06 ,pp. : 97-105

Springer Publishing Company

Access to resources Recommend Favorite

A Potential New Tool for Managing Clostridium difficile Infection

By Armstrong Glen D.   Pillai Dylan R.   Louie Thomas J.   MacDonald Justin A.   Beck Paul L.  

The Journal of Infectious Diseases, Vol. 207, Iss. 10, 2013-05 ,pp. : 1484-1486

Oxford University Press

Access to resources Recommend Favorite